#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Mikhail Hammond Email
Director, Bioanalytical Sciences . Amunix Pharmaceuticals
Mountain View, CA
Locationm*******@amunix.com
Primary EmailHow to contact Mikhail Hammond
Join and see Mikhail's contact info for free!m*******@amunix.com
Phone
847494****
GROWJO
The Free Company & People Database
Current Roles
Amunix Pharmaceuticals
Get all of our best features!
About
Amunix is leveraging our expertise in precision protein engineering to enable the promise of T cell engagers in solid tumors. Our goal is to save cancer patientsￃﾢ￢ﾂﾬ￢ﾄﾢ lives through the development and commercialization of breakthrough therapies that harness the immune system. We have invented XTEN, a validated therapeutic half-life extension technology. Our current focus is Pro-XTEN, a next-generation protease activated pro-drug platform, which enables selective activation of potent cancer therapies in the tumor microenvironment. This overcomes a common challenge facing potent immune system activators: on-target, off-tumor toxicity. Amunixￃﾢ￢ﾂﾬ￢ﾄﾢs two lead programs employ the Pro-XTEN technology to enhance the safety profile of T cell engagers. XPATs (XTENylated Protease-Activated T Cell Engagers) have the potential to make off-the-shelf therapies redirecting T cells to solid tumors a reality. Amunixￃﾢ￢ﾂﾬ￢ﾄﾢs robust technology has been validated through multiple collaborations with leading biopharmaceutical companies including Celgene, Genentech, Janssen, Roche, and Bioverativ (now Sanofi). In addition, XTENylated drugs have been dosed in greater than 200 patients with minimal immunogenicity against XTEN. Amunix is currently located in Mountain View, CA but is moving to South San Francisco in 2020.Amunix Pharmaceuticals Address
2 Tower Pl #1100Mountain View, CA
United States